Purchases and Sales Made in Q3 2021 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q3 2021. The information is specifically focused on institutions that hold shares of Celldex Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2021
Q3 2021
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-142K- 11.48% |
$4.12M - $7.97M
|
1.1M
$26.1M
|
|
|
Nov 15, 2021
Q3 2021
|
Tri Locum Partners LP
New York, NY |
SELL
|
- |
-175KClosed |
$5.08M - $9.82M
|
0
$0
|
|
|
Nov 12, 2021
Q3 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-203K- 55.7% |
$5.87M - $11.4M
|
161K
$3.84M
|
|
|
Nov 09, 2021
Q3 2021
|
Candriam S.C.A.
|
SELL
|
- |
-219K- 54.91% |
$6.35M - $12.3M
|
180K
$4.29M
|
|
|
Nov 15, 2021
Q3 2021
|
State Street Corp
Boston, MA |
SELL
|
- |
-237K- 11.32% |
$6.86M - $13.3M
|
1.86M
$44.2M
|
|
|
Nov 15, 2021
Q3 2021
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-349K- 47.0% |
$10.1M - $19.5M
|
394K
$9.37M
|
|
|
Nov 15, 2021
Q3 2021
|
Cresset Asset Management, LLC
Chicago, IL |
SELL
|
- |
-458KClosed |
$13.2M - $25.6M
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-484K- 50.0% |
$14M - $27.1M
|
484K
$11.5M
|
|
|
Nov 15, 2021
Q3 2021
|
Acuta Capital Partners, LLC
Belmont, CA |
SELL
|
- |
-650K- 65.82% |
$18.8M - $36.4M
|
338K
$8.03M
|
|
|
Nov 15, 2021
Q3 2021
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-868K- 47.76% |
$25.1M - $48.6M
|
950K
$22.6M
|
|
|
Nov 15, 2021
Q3 2021
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-981K- 46.51% |
$28.4M - $54.9M
|
1.13M
$26.8M
|